Japan Shoots For 'Zero' Device Lag With Review Time Targets
This article was originally published in SRA
Japan is taking steps to eliminate the notorious time lag associated with its regulatory approval of medical devices by introducing new measures to speed up the review process. For this, it has adopted a different approach under which the speed of the review process is determined by how urgently a new product is needed to address a medical need.
You may also be interested in...
With less than one hundred days left before the European Union Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss growing concerns by medtech industry members that they may not be ready in time to comply with these regulations and may inadvertently go afoul of the new regulations.
What will the fall-out of political tensions between the EU and Switzerland mean for notified bodies based in Switzerland, and for the future recognition of CE marks granted in one of the most important medtech markets in Europe?
Eighteen years of free trade threatens to come to a sudden stop, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.